Intellia Therapeutics
NTLA
#5769
Rank
C$1.53 B
Marketcap
C$13.28
Share price
-1.33%
Change (1 day)
-36.25%
Change (1 year)

Intellia Therapeutics (NTLA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.24 Billion

According to Intellia Therapeutics's latest financial reports the company's total liabilities are C$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Intellia Therapeutics - Total liabilities on balance sheet (from 2015 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.45 B37.63%
2023-12-31C$0.33 B-13.84%
2022-12-31C$0.38 B19.17%
2021-12-31C$0.32 B70.25%
2020-12-31C$0.19 B126.26%
2019-12-31C$84.1 M-11.02%
2018-12-31C$94.52 M-0.6%
2017-12-31C$95.09 M-20.61%
2016-12-31C$0.11 B-16.44%
2015-12-31C$0.14 B3849.15%
2014-12-31C$3.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
C$33.53 M-86.28%๐Ÿ‡บ๐Ÿ‡ธ USA